FDA Cancels Cipla's Pune Warehouse Licenses
The story in brief
The Maharashtra FDA canceled Cipla Pharma's drug sale and distribution licenses at its Wadki warehouse in Pune due to unauthorized packaging claims and storage deficiencies. The decision followed fresh proceedings ordered by the Bombay High Court, with Cipla reviewing the order and considering further steps. The cancellation disrupts the warehouse's operations and highlights regulatory scrutiny of pharmaceutical compliance.